Related Experiment Video
Updated: May 25, 2026

Focus Formation: A Cell-based Assay to Determine the Oncogenic Potential of a Gene
Published on: December 31, 2014
MdmX is required for p53 interaction with and full induction of the Mdm2 promoter after cellular stress
Lynn Biderman1, Masha V Poyurovsky, Yael Assia
1Department of Biological Sciences, Columbia University, New York, New York, USA.
Abstract:
The activity of the tumor suppressor p53 is tightly controlled by its main negative regulator, Mdm2, which inhibits p53's transcriptional activity and targets it for degradation via the proteasome pathway. The closely related Mdm2 homolog, MdmX, is also considered to be a general inhibitor of transactivation by p53, through binding to the p53 activation domain. We show here that, unexpectedly, upon DNA damage and ribosomal stress, MdmX plays a positive role in p53-mediated activation of the Mdm2 gene, but not of numerous other p53 target genes including p21. Downregulation of MdmX results in lower levels of mature and nascent Mdm2 transcripts following cellular stress. This correlates with a longer p53 half-life following DNA damage. In vitro, Mdm2 inhibits the binding of p53 to DNA to a much greater extent than does MdmX, although MdmX does not stimulate p53 interaction with Mdm2 promoter DNA. Strikingly, however, MdmX is required for optimal p53 binding to the Mdm2 promoter in vivo. Thus, we have described a new mechanism by which MdmX can suppress p53, which is through transcriptional activation of p53's principal negative regulator, Mdm2.
Insights
MdmX unexpectedly promotes Mdm2 gene activation by tumor suppressor p53 during cellular stress. This novel mechanism reveals MdmX
Area of Science:
- Molecular Biology
- Cancer Biology
- Cellular Stress Response
Background:
- The tumor suppressor p53 is regulated by Mdm2, a negative regulator that inhibits p53 activity and promotes degradation.
- MdmX, a homolog of Mdm2, also inhibits p53 transactivation by binding to its activation domain.
Purpose of the Study:
- To investigate the role of MdmX in p53-mediated gene activation, particularly concerning Mdm2.
- To elucidate the mechanism by which MdmX influences p53 activity under cellular stress conditions.
Main Methods:
- Analysis of MdmX's effect on p53-mediated activation of Mdm2 and other target genes (e.g., p21) following DNA damage and ribosomal stress.
- Assessment of Mdm2 and p53 transcript levels and p53 half-life upon MdmX downregulation.
- In vitro and in vivo studies examining the binding interactions between p53, Mdm2, and MdmX with the Mdm2 promoter DNA.
Main Results:
- MdmX unexpectedly promotes p53-mediated activation of the Mdm2 gene, but not other p53 target genes, following DNA damage and ribosomal stress.
- Downregulation of MdmX leads to reduced Mdm2 transcript levels and an increased p53 half-life after cellular stress.
- While Mdm2 inhibits p53-DNA binding more potently than MdmX in vitro, MdmX is essential for optimal p53 binding to the Mdm2 promoter in vivo.
Conclusions:
- MdmX plays a novel positive role in the transcriptional activation of Mdm2 by p53 under stress conditions.
- A new mechanism is identified where MdmX suppresses p53 activity by transcriptionally activating its negative regulator, Mdm2.
- These findings reveal a complex regulatory feedback loop involving p53, Mdm2, and MdmX in cellular stress response and tumor suppression.
Related Concept Videos
Abnormal Proliferation
DNA Damage Can Stall the Cell Cycle
DNA Damage can Stall the Cell Cycle
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Negative Regulator Molecules

